BlackRock (NYSE: BLK), has disclosed a 5.4% ownership stake in biopharmaceutical company Sellas Life Sciences.
Stocktwits on MSN
SELLAS Life Sciences Stock Rises On Strong Preclinical Data For Investigational Cancer Treatment
SELLAS Life Sciences Group (SLS) announced on Monday that preclinical data support its SLS009 as a monotherapy or in combination with Venetoclax for treating a rare and highly aggressive form of ...
Preclinical data support SLS009 as a monotherapy or in combination with venetoclax for the treatment of T-PLL, a rare and highly aggressive form of mature T-cell leukemiaNEW YORK, Oct. 13, 2025 (GLOBE ...
SLS Hotels & Residences has unveiled its first all-inclusive property, the SLS Playa Mujeres, located just 15 miles north of Cancun International Airport. Situated in a gated beachfront community, the ...
International luxury hospitality group SLS will make its brand debut in Europe with the opening of an outpost in Barcelona this fall. In the meantime, the company has unveiled a new branded project, a ...
SELLAS Life Sciences Gr (NASDAQ:SLS) just reported results for the second quarter of 2024. SELLAS Life Sciences Gr reported earnings per share of -13 cents. This was above the analyst estimate for EPS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback